Download Now: Exclusive Guide About India's Potentially Decade-Long $10 Trillion Bull Run...
Here is the latest financial fact sheet of GODAVARI DRU. For more details, see the GODAVARI DRU quarterly results and GODAVARI DRU share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.2 |
No. of shares | m | 7.53 |
1 Week | % | 5.3 |
1 Month | % | 10.9 |
1 Year | % | 29.5 |
52 week H/L | Rs | 114.0/76.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
GODAVARI DRU EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 36 | 25 | 60 | 84 | 102 | |
Low | Rs | 17 | 9 | 10 | 45 | 52 | |
Sales per share (Unadj.) | Rs | 110.9 | 127.1 | 162.9 | 214.0 | 212.0 | |
Earnings per share (Unadj.) | Rs | 1.6 | 2.7 | 5.5 | 7.0 | 5.0 | |
Diluted earnings per share | Rs | 1.6 | 2.7 | 5.5 | 7.0 | 5.0 | |
Cash flow per share (Unadj.) | Rs | 3.0 | 4.2 | 7.1 | 9.2 | 7.6 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 24.2 | 26.9 | 32.4 | 39.4 | 44.4 | |
Adj. book value per share | Rs | 24.2 | 26.9 | 32.4 | 39.3 | 44.4 | |
Shares outstanding (eoy) | m | 7.53 | 7.53 | 7.53 | 7.53 | 7.53 | |
Price / Sales ratio | x | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 | |
Avg P/E ratio | x | 16.4 | 6.4 | 6.3 | 9.2 | 15.3 | |
P/CF ratio (eoy) | x | 8.6 | 4.1 | 4.9 | 7.0 | 10.1 | |
Price / Book Value ratio | x | 1.1 | 0.6 | 1.1 | 1.6 | 1.7 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 198 | 129 | 262 | 483 | 580 | |
Total wages/salary | Rs m | 35 | 34 | 39 | 50 | 48 |
GODAVARI DRU INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 835 | 957 | 1,227 | 1,611 | 1,596 | |
Other income | Rs m | 2 | 3 | 4 | 3 | 7 | |
Total revenues | Rs m | 838 | 960 | 1,231 | 1,614 | 1,603 | |
Gross profit | Rs m | 55 | 60 | 98 | 113 | 102 | |
Depreciation | Rs m | 11 | 12 | 12 | 17 | 19 | |
Interest | Rs m | 29 | 29 | 33 | 28 | 39 | |
Profit before tax | Rs m | 17 | 23 | 57 | 70 | 49 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 5 | 3 | 16 | 18 | 11 | |
Profit after tax | Rs m | 12 | 20 | 41 | 52 | 38 | |
Gross profit margin | % | 6.6 | 6.3 | 8.0 | 7.0 | 6.4 | |
Effective tax rate | % | 30.8 | 12.6 | 27.7 | 25.3 | 23.3 | |
Net profit margin | % | 1.4 | 2.1 | 3.4 | 3.3 | 2.4 |
GODAVARI DRU BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 565 | 608 | 676 | 743 | 870 | |
Current liabilities | Rs m | 462 | 512 | 505 | 578 | 737 | |
Net working cap to sales | % | 12.3 | 10.0 | 13.9 | 10.3 | 8.3 | |
Current ratio | x | 1.2 | 1.2 | 1.3 | 1.3 | 1.2 | |
Inventory Days | Days | 1 | 1 | 1 | 1 | 1 | |
Debtors Days | Days | 148,350,640 | 137,377,572 | 1,343 | 1,259 | 1,325 | |
Net fixed assets | Rs m | 172 | 231 | 235 | 271 | 344 | |
Share capital | Rs m | 75 | 75 | 75 | 75 | 75 | |
"Free" reserves | Rs m | 107 | 127 | 169 | 221 | 259 | |
Net worth | Rs m | 183 | 203 | 244 | 296 | 334 | |
Long term debt | Rs m | 80 | 112 | 145 | 118 | 119 | |
Total assets | Rs m | 737 | 839 | 911 | 1,014 | 1,214 | |
Interest coverage | x | 1.6 | 1.8 | 2.7 | 3.5 | 2.3 | |
Debt to equity ratio | x | 0.4 | 0.6 | 0.6 | 0.4 | 0.4 | |
Sales to assets ratio | x | 1.1 | 1.1 | 1.3 | 1.6 | 1.3 | |
Return on assets | % | 5.6 | 5.9 | 8.2 | 8.0 | 6.4 | |
Return on equity | % | 6.6 | 9.9 | 16.9 | 17.7 | 11.3 | |
Return on capital | % | 17.7 | 16.6 | 23.2 | 23.8 | 19.5 | |
Exports to sales | % | 2.0 | 0.2 | 1.0 | 1.2 | 0.4 | |
Imports to sales | % | 64.7 | 60.2 | 62.1 | 62.7 | 60.3 | |
Exports (fob) | Rs m | 16 | 2 | 12 | 19 | 7 | |
Imports (cif) | Rs m | 540 | 576 | 761 | 1,009 | 962 | |
Fx inflow | Rs m | 16 | 2 | 12 | 19 | 7 | |
Fx outflow | Rs m | 541 | 577 | 761 | 1,009 | 963 | |
Net fx | Rs m | -525 | -575 | -749 | -990 | -956 |
GODAVARI DRU CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 37 | 62 | 13 | 112 | 132 | |
From Investments | Rs m | -23 | -67 | -13 | -50 | -86 | |
From Financial Activity | Rs m | -15 | 3 | 1 | -56 | -38 | |
Net Cashflow | Rs m | -1 | -1 | 2 | 6 | 8 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Ghanshyam Jaju | COMP SEC: Narendra Maddineni | YEAR OF INC: 1987 | BSE CODE: 530317 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare GODAVARI DRU With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.